Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC)
Main Authors: | Hebert Jacques, Nolte Hendrik, Maloney Jennifer, Blaiss Michael, Nelson Harold S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Similar Items
-
A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
by: Michael Blaiss, et al.
Published: (2023-10-01) -
Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis
by: Rønborg SM, et al.
Published: (2012-09-01) -
Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis
by: Anne K. Ellis, et al.
Published: (2021-12-01) -
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
by: Anne K. Ellis, et al.
Published: (2023-01-01) -
A survey on the perception of allergy specialists about the reimbursed grass pollen tablets for seasonal allergic rhinitis in Italy
by: Ilaria Massaro, et al.
Published: (2017-08-01)